The authors of the research from the National University of Singapore tested 7,356 X-ray images of wrist taken from the hospital picture and archiving system using object detection CNN. With the help of bounding boxes, the radiologists marked the ulna fractures and the radius of the images. They then subjected the CNN model to the test programmed on an invisible test group of 524 ED wrist radiographic studies. The result was impressive and the AI, used along deep learning orthopedic radiographs, surpassed previous works.
It was able to identify and confine the ulna fractures and radius on the X-ray images with a high level of sensitivity. That is 91.2 percent on the frontal and 96.3 percent on the lateral of the per-fracture level. In the per-image level, it was able to detect 95.7 percent on the frontal and 96.7 percent on the lateral. Based on the per-study level, the test was able to identify 98.1 percent. These are based on fairly moderate dataset training size.
The processing time of each test image only takes 0.18 seconds. The test also revealed no substantial variance in the performance of the algorithm between images that belong to pediatric and adult patients. Remarkably, there was no noteworthy difference whether the image of the wrist was in a cast or the time frame when it was taken. This latest healthcare technology news could be very useful to further augment the work of pressured ER doctors and Radiologists.
The latest report was written by healthcare attorney David Harlow and CareSet Systems CTO and hacktivist Fred Trotter. It claims that the popular social networking site puts the health of its users at risk by its manner of handling their personal health information. The document argues that while the social networking site dynamically encourages to share their personal health information in various ways, set of access and privacy control are not consistently applied.
In addition, the report claims that Facebook, as a PHR or personal health record platform violated the FTC Health Breach Notification rule when it permitted a significant number of patient health information to leak. Andrea Downing, the co-author of the complaint and co-moderator of a group for patients with breast cancer, pointed out one of the social networking site’s vulnerabilities.
She claimed that the Group system of the social media site is vulnerable to SICGRL otherwise known as Strict Inclusion Closed Group Reverse Lookup attack. When this happens, a closed group discloses its list of members to all Facebook users. The vulnerability report notes that this functionality is equivalent to publishing personal information of the user that is not supposedly intended for the public. It can be recalled that in 2018, healthcare technology news sites reported how a patient advocate the same security problem with the closed groups on Facebook.
Recently, the U.S.-China Economic and Security Review Commission reported that China has been very aggressive in augmenting its investment in the biotechnology sector of the US in recent years. This allowed them to gain access to the medical, genetic, and private data of US citizens, which could be a potential security risk.
Gryphon Scientific and Rhodium Group furnished the report titled “China’s Biotechnology Development” that landed on the headlines of various healthcare technology news websites. The US Congress created the commission in order to assess and study the implications in terms of national security of the trade and economic relationship of the two countries.
The report identified that the Chinese government acknowledged the significance of data from healthcare in their biotechnology advancement. Various Chinese biotech companies have access to data and technology through diverse investments in the US. This includes staffing of US-trained and American researchers, investments in American companies, and partnerships with US schools and universities.
The latest US regulations have placed biotech on the same level of importance as microchips and aerospace in terms of national security. Pitchbook reported that in 2018, at least one Chinese investor joined in 41 American biotech financing deals. This is equivalent to approximately $2.6 billion.
The commission report noted that China is the primary instigator of various cyber attacks on the US that aim at data that are healthcare related. However, it downplayed the risk and claimed that so far there was no evidence linking the Chinese government using these data in a tactical and hostile manner.
BC Platforms announced that it will provide its famed genomics platform to Bumrungrad International Hospital. BC Platforms CEO Tero Silvola revealed that they are pleased that the multi-specialty medical center in Thailand and one of the largest healthcare providers in Southeast Asia would like to adopt their platform in their benefit research as well as in their clinical practice.
The partnership aims to create all-inclusive alliance programs based on the latest innovations to build projects that will greatly benefit the patients. In addition, the collaboration intends to get access to various clinical trials significant to their specific disease status. With Bumrungrad’s data, primarily focused on Asian genetics, on the BCRQUEST, Silvola said that they can advance the diversity of their service to various research institutions all over the world.
BCRQUEST is a worldwide network consists of biobanks and healthcare service providers that offer clinical information as well as genomics. This data is used in medical and pharmaceutical research and development. In addition, Bumrungrad wishes to provide for each of their patients a more personal and customized health care solutions.
This can be achieved by utilizing the end to end software Software-as-a-Service platform of BC Platforms. The fundamental system will be impeccably incorporated in the medical center infrastructure from electronic patient records up to the laboratory.